Archive for January, 2009

Reproductive Health Matters - Hormonal contraception and risk of HIV acquisition: Uganda and Zimbabwe

Monday, January 12th, 2009

This study among 6,109 HIV-negative women recruited from family planning clinics who were using either Depo Provera or combined oral contraception in Uganda and Zimbabwe tested the women quarterly for HIV over 15-24 months. 213 women became HIV positive during the study. Neither hormonal contraceptive method was associ…

Business Wire - Pharmacia and Upjohn Will Appeal Verdict in Simon Case, ‘Ruling is Not Supported by the Evidence’

Friday, January 9th, 2009

NEW YORK — Pfizer said its subsidiary, Pharmacia and Upjohn, will appeal today’s jury verdict linking its product, Provera, with plaintiff Merle Simon’s breast cancer. The case, Simon vs. Wyeth, et al., was heard in the Philadelphia Court of Common Pleas.
“While we have great sympathy for what Mrs. Simon and her family have been through, today’s verdict is neither supported by the evidence introduced during the trial …

British Plastics & Rubber - Cut costs by extruding wider rolls.(film & sheet production)

Thursday, January 8th, 2009

A COEXTRUSION cast line for stretch film 5 metres wide with up to seven layers has been demonstrated by Adtech Provera of Italy.

Related Results

Depo-Provera/NorplantDepo-Provera: the quarterly contraceptiveDepo-Provera approved by FDAComparing Norplant and Depo-ProveraFIA slams Provera over Cyp…

OB/GYN News - Bone loss related to Depo-Provera reverses after discontinuing therapy

Sunday, January 4th, 2009

Bone loss associated with depot medroxyprogesterone acetate was reversible in a prospective population-based cohort study.
In 183 nonpregnant, reproductive-age users of the injectable contraceptive, which is sold as Depo-Provera, bone density at the spine changed at an annualized mean rate of -0.87%, comp…